Report Finds Significant Catastrophic Liability for Drug Makers Benefits Seniors, Taxpayers Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) said Tuesday that a new study from Oliver Wyman analyzing different cost sharing scenarios underscores the critical need to hold Big Pharma accountable in Medicare Part D reform. “Without more skin in the game, […]
Washington, D.C. – The U.S. Senate Special Committee on Aging held its third hearing on the “Complex Web of Prescription Drug Prices” on Wednesday. Senators from both sides of the aisle called for action to lower drug prices for not only seniors, but all patients, and hit Big Pharma for the industry’s anti-competitive and price-gouging […]
Current Trade Agreement Could Hamper Generic and Biosimilar Competition Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) sent a letter to members of Congress today detailing concerns with the proposed U.S.-Mexico-Canada Agreement (USMCA) and asking lawmakers to address those concerns to protect American patients. “CSRxP believes that trade agreements are important tools to […]
Greater List Price Transparency Will Help Crack Down on Big Pharma’s Price-Gouging Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today ahead of a U.S. Senate Health, Education, Labor and Pensions (HELP) Committee legislative hearing Tuesday to encourage the committee to take up the Fair Accountability and Innovative Research (FAIR) […]
Drug Makers Intensify Blame Game While Seeking to Avoid Accountability Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today issued a statement after fresh evidence that PhRMA and BIO, the principal trade groups representing Big Pharma, have ramped-up their blame game tactics targeting others in the health care system to avoid accountability for […]
Poll Finds U.S. Adults Blame Drug Makers for Rising Prices, Oppose Administration’s Rebate Rule and See Value in PBMs Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday on a new national survey that found an overwhelming 84 percent of Americans want policymakers to focus on policies that crack down […]
Bipartisan CREATES, FAIR Drug Pricing and REMEDY Acts Will Deliver Relief for American Patients Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today issued a statement on comments submitted to Chairman Lamar Alexander (R-TN) and Ranking Member Patty Murray (D-WA) of the U.S. Senate Health, Education, Labor and Pensions (HELP) Committee on ways […]
Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement ahead of two days of hearings before the U.S. Senate Committee on the Judiciary Subcommittee on Intellectual Property on the “State of Patent Eligibility in America.” “At a time when one in four Americans cannot afford their medications, it is important […]
NGA’s “2019 Principles for Federal Action to Address Health Care Costs” Back Greater Competition, Boosted Transparency Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement in response to recommendations released by the National Governors Association (NGA) titled “2019 Principles for Federal Action to Address Health Care Costs.” “We applaud America’s […]
Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday on the introduction of a package of health care legislation from U.S. Senate Committee on Health Care, Education, Labor and Pensions (HELP) Chairman Alexander and Ranking Member Murray. “We appreciate the bipartisan commitment of Chairman Alexander and Ranking Member Murray to […]